Lipoxygenase inhibition: the neglected frontier for regulating chronic inflammation and pain M. W. WhitehouseK. D. Rainsford Editorial Pages: 99 - 102
Professor William Watson Buchanan, MB ChB, MD, FRCP (Glas., Edin., C.), FRACP, FRCP (Hon; Ireland), FACR (Hon) Obituary Pages: 103 - 119
Current status of the therapeutic uses and actions of the preferential cyclo-oxygenase-2 NSAID, nimesulide K. D. Rainsford Review Pages: 120 - 137
Therapeutic use of cephazolin to prevent complications of spine surgery R. WaltersB. Vernon-RobertsR. Moore Research Article Pages: 138 - 143
Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation B. L. SlomianyA. Slomiany Research article 01 August 2006 Pages: 144 - 149
Paracetamol [acetaminophen]-induced gastrotoxicity: revealed by induced hyperacidity in combination with acute or chronic inflammation K. D. RainsfordM. W. Whitehouse Research Article Pages: 150 - 154
Reduced inflammatory potential of peritoneal macrophages recruited in mice pretreated with a glycolipid synthesis inhibitor H. C. YoheT. J. KitzmillerJ. F. Sinclair Short Communication Pages: 155 - 160
Arthritic disease suppression and cartilage protection with glycosaminoglycan polypeptide complexes (Peptacans) derived from the cartilage extracellular matrix: a novel approach to therapy P. GhoshS. ShimmonM. W. Whitehouse Research Article Pages: 161 - 168
Protective effects of nedocromil sodium and sodium cromoglycate on gastroduodenal ulcers: a comparative study in rats Mohammad TariqMeshal Al MoutaeryHaseeb Ahmad Khan Research Article Pages: 169 - 175